SMS Lifesciences (SMSLIFE) | Stock Overview & Key Data
SMS Lifesciences Performance Comparison
Stock Range
Today's Range
Low: ₹1,074.40
High: ₹1,099.90
on August 18, 2025
52 Week Range
Low: ₹959.80
High: ₹1,749.65
on March 4, 2025
on September 9, 2024
All-Time High: ₹1,749.65 on September 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR3.3B
EPS
66.52
P/E Ratio (TTM)
16.23
Forward P/E
N/A
P/B Ratio
1.66
PEG Ratio
N/A
Div. Yield
0.13%
ROE
9.48%
Beta
0.262
Debt to Equity
40.75
Financial Highlights
Profitability
Gross Margin
36.80%
Operating Margin
9.56%
Profit Margin
5.17%
Returns and Earnings
Return on Assets (TTM)
5.16%
Return on Equity (TTM)
9.48%
EBITDA
INR499.0M
Net Income (TTM)
INR173.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR1,107.01
Quarterly Revenue Growth (YoY)
-10.90%
Quarterly Earnings Growth (YoY)
-40.60%
Dividend Information
Last 12-Month Dividend
₹1.50
Current Dividend Yield
0.13%
3-Year Average Dividend Yield
0.20%
3-Year Average Annual Dividend
₹1.50
3-Year Total Dividends
₹4.50
Ex-Dividend Date
September 23, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| SMS Lifesciences SMSLIFE | 3.27B Small-cap | -4.95% | -6.02% | -24.71% | -16.48% | -9.97% | -17.32% | 62.22% | 127.80% |
| Biocon BIOCON | 479.58B Large-cap | -1.36% | -5.24% | 6.22% | 2.83% | -2.59% | 5.37% | 16.58% | -8.83% |
| OneSource Specialty ONESOURCE | 215.42B Large-cap | 0.15% | -6.26% | 17.38% | 30.15% | 9.77% | 9.77% | 9.77% | 9.77% |
| Dishman Carbogen DCAL | 41.98B Small-cap | 11.66% | 7.15% | 25.68% | 31.80% | -6.20% | 52.87% | 123.65% | 38.08% |
| Zota Health Care ZOTA | 35.41B Small-cap | 13.73% | 13.34% | 42.86% | 56.66% | 72.94% | 112.99% | 414.75% | 879.05% |
| Panacea Biotec PANACEABIO | 25.78B Small-cap | 2.35% | -1.18% | -25.78% | 24.96% | -4.38% | 154.90% | 209.35% | 161.37% |
Ownership & Short Interest
Insider Ownership
74.01%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
5K
Average 90-Day Volume
7K
SMS Lifesciences Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in SMS Lifesciences would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SMSLIFE's 52-week high and low?
- In the last 52 weeks, SMS Lifesciences reached a high of ₹1,749.65 (on September 9, 2024) and a low of ₹959.80 (on March 4, 2025).
- What is the market cap and P/E ratio for SMSLIFE?
- Curious about SMS Lifesciences's size and valuation? Its market capitalization stands at 3.27B. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.23, and the forward P/E (looking ahead) is N/A.
- Does SMSLIFE pay dividends? If so, what's the yield?
- Yes, SMS Lifesciences is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.13%, and the company has paid an average of ₹1.50 per share annually over the past 3 years.
- Who are SMS Lifesciences's main competitors or similar companies to consider before investing?
When looking at SMS Lifesciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON479.58B Healthcare Biotechnology 5.37% 16.58% OneSource Specialty
ONESOURCE215.42B Healthcare Biotechnology 9.77% 9.77% Dishman Carbogen
DCAL41.98B Healthcare Biotechnology 52.87% 123.65% Zota Health Care
ZOTA35.41B Healthcare Biotechnology 112.99% 414.75% Panacea Biotec
PANACEABIO25.78B Healthcare Biotechnology 154.90% 209.35% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for SMS Lifesciences India Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of SMS Lifesciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 9.48%, the Debt to Equity ratio from the most recent quarter is 40.75, and its Gross Profit Margin stands at 36.80%.
- What is the recent revenue and earnings growth for SMSLIFE?
- Looking at SMS Lifesciences's growth, its revenue over the trailing twelve months (TTM) was INR3B. Compared to the same quarter last year (YoY), quarterly revenue grew by -10.90%, and quarterly earnings saw a YoY growth of -40.60%.
- How much of SMSLIFE stock is held by insiders and institutions?
- Wondering who owns SMS Lifesciences stock? Company insiders (like executives and directors) hold about 74.01% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.